How can we direct managed care to benefit pediatrics?

被引：0

作者：

Kanto, WP ^{[1
]}

机构：

[1] Med Coll Georgia, Dept Pediat, Off Chairman, Augusta, GA 30912 USA

来源：

PEDIATRIC ANNALS | 1998年 / 27卷 / 08期

关键词：

D O I：

10.3928/0090-4481-19980801-05

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Could the improvements in pediatric health care over the past 30 years have been accomplished in an environment of managed care? Read on for strategies to ensure continuing advances in caring for patients.

引用

页码：482 / +

页数：4

共 50 条

[1] Why is copper toxic, and how can we direct it for benefit?
Franz, Katherine
JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S132 - S132
[2] How managed care can be ethical
Randel, L
Pearson, SD
Sabin, JE
Hyams, T
Emanuel, EJ
HEALTH AFFAIRS, 2001, 20 (04) : 43 - 56
[3] Integrative health care: How can we determine whether patients benefit?
Verhoef, MJ
Mulkins, A
Boon, H
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2005, 11 : S57 - S65
[4] Surveillance Information - How we can all Benefit
Watson, E.
CATTLE PRACTICE, 2010, 18 : 76 - 82
[5] How can we improve the reach of clinical hypnosis in medicine and pediatrics?
Anbar, Ran D.
AMERICAN JOURNAL OF CLINICAL HYPNOSIS, 2024, 66 (04) : 301 - 303
[6] Can we be faithful to the Hippocratic oath in the era of managed care?
Healy, GB
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1998, 124 (05) : 497 - 498
[7] Literacy promotion in primary care pediatrics: Can we make a difference?
High, PC
LaGasse, L
Becker, S
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 1999, 20 (05): : 403 - 404
[8] Literacy promotion in primary care pediatrics: Can we make a difference?
High, PC
LaGasse, L
Becker, S
Ahlgren, I
Gardner, A
PEDIATRICS, 2000, 105 (04) : 927 - 934
[9] Nephrostomies in obstructive uropathy; how should hormone resistant prostate cancer patients be managed and can we predict who will benefit?
M R E Harris
M J Speakman
Prostate Cancer and Prostatic Diseases, 2006, 9 : 42 - 44
[10] Nephrostomies in obstructive uropathy; how should hormone resistant prostate cancer patients be managed and can we predict who will benefit?
Harris, MRE
Speakman, MJ
PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (01) : 42 - 44

← 1 2 3 4 5 →